IL1B and endometriosis: Both conditions also exhibit dysregulation of the IL-1β/IL-1RA axis, with endometriosis patients showing increased peritoneal IL-1β41 (a potent pyrogen and pain mediator) and ME/CFS patients demonstrating elevated systemic IL-1RA [45], suggesting chronic but ineffective anti-inflammatory compensation.